VAERS reports by lot

Seqirus / CSL Flu lot 195212: VAERS reports

24 VAERS reports list lot 195212 as a Seqirus / CSL Flu vaccine, received between 2017-09-12 and 2019-01-25. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
21%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2222%
Injection-site / Local reaction2222%
General / Systemic (non-local)1212%
Musculoskeletal1010%
Allergic / Anaphylactic77%
Dermatological (non-injection-site)77%
Cardiac / Cardiovascular66%
Respiratory55%
Gastrointestinal55%
Psychiatric / Neuropsychiatric33%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
Ohio2
Maryland2
Virginia1
Massachusetts1
Michigan1
New York1
Missouri1
Pennsylvania1
Texas1
Rhode Island1
Kentucky1

Reports by month received

2017-091
2017-1010
2017-116
2017-121
2018-013
2018-021
2018-041
2019-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.